Clinical outcomes non insulin requiring diabetes

Clinical outcomes non insulin requiring diabetes

FreeStyle Libre is clinically proven to reduce HbA1c in people living with type 2 diabetes (T2D)15,17,21,22

Non-insulin therapy

 A1c inside a circle next to a wide blue downwards arrow showing a decrease of 1.6 percent.

After 22 weeks

In people with T2D who were using non-insulin therapy and FreeStyle Libre (p<0.001 vs. baseline A1c)21

A downward pointing yellow arrow.

Baseline A1c:


Follow-up A1c:


FreeStyle Libre has been proven to increase Time in Range by 43%3

time in range cgm

More frequent scanning of the FreeStyle Libre sensor has been proven to increase Time in Range

Lowering HbA1c reduces your risk of diabetes related complications

Use of the FreeStyle Libre system is associated with significant reduction in diabetes-related hospital admissions8,11

Reduction in hospital admissions by 66 percent

Reduction in hospital admissions

Use of FreeStyle Libre reduced diabetes related hospital admissions11

Reduction in work absenteeism by 58 percent

Reduction in work absenteeism

Use of FreeStyle Libre led to reduction in work absenteeism over 1 year11

Disclaimer – Images are for illustration purpose only. No actual patient data. Any person depicted in the photos is a model

Abbreviations: HbA1c: glycated haemoglobin; MDI: multiple daily injections; SMBG: self-monitoring of blood glucose; T2D: type 2 diabetes.